SWOG clinical trial number
SWOG-9035

Randomized Trial of Adjuvant Immunotherapy with an Allogeneic Melanoma Vaccine for Patients with Intermediate Thickness, Node Negative Malignant Melanoma (T3N0M0), Phase III.

100% Accrual
Accrual
100%
Closed
Phase
100% Accrual
Accrual
100%
Published
Abbreviated Title
Randomized Trial of Adjuvant Immunotherapy with an Allogeneic Melanoma Vaccine for Patients with Intermediate Thickness, Node Negative Malignant Melanoma (T3N0M0), Phase III.
Activated
04/15/1992
Closed
11/15/1996

Research committees

Melanoma

Other Clinical Trials

S2000
SWOG Clinical Trial Number
CTSU/EA6174
SWOG Clinical Trial Number